Dan Wolff Prof. Wolff is Chair of the multidisciplinary GVHD Center of the University Hospital Regensburg, Germany. His work focuses on pathophysiology and treatment of chronic GVHD and he is a member of the steering committee of the NIH Consensus on cGVHD 2020 and chair of the German-Austrian-Swiss GVHD consortium.
Management of chronic GVHD – Monday, December 16, 2024 Read More »
Florent Malard Florent Malard is Professor of Hematology at the Saint-Antoine Hospital and Sorbonne University. Florent Malard was a visiting investigator at the Memorial Sloan Kettering Cancer Center in New-York, USA from 2015-2016. He is now a researcher at the Saint-Antoine research Center in Paris and his research focus on Graft-versus-Host disease, microbiota and immunological
Diagnosis and management of acute GVHD – Monday, November 4, 2024 Read More »
Steven Pavletic Dr. Pavletic is a an expert in chronic graft-versus-host disease (cGVHD); his clinical studies focus on improving treatment for patients with cGVHD. Dr. Pavletic has led national and international efforts to develop consensus guidelines for cGVHD clinical trials. Currently, he directs the NIH cGVHD Study Group and the NIH Myeloid Malignancies Clinical Program,
Diagnosis and grading of chronic GVHD – Monday, November 25, 2024 Read More »
Rafael Duarte Rafael F. Duarte, MD, PhD, FRCP, Head of Department of Hematology at Hospital Puerta de Hierro in Madrid. He is a HSCT physician and scientist with particular interest in infective and non-infective complications of transplant and cellular therapies, past-chair of the EBMT Transplant Complications Working Party, past-Secretary of the Society and EBMT Congress
Early transplant complications: a focus on VOD diagnosis Read More »
Zinaida Perić Zinaida Peric MD, PhD, hematologist /transplant physician at the Bone Marrow Transplant Unit at the University Hospital Centre Zagreb and a postdoctoral research assistant at the School of Medicine, University of Zagreb.
Chronic GVHD: prevention and management of long-term complications Read More »
Mohamad Mohty Mohamad Mohty, MD, PhD, Professor of Hematology and Head of the Hematology and Cellular Therapy Department at the Saint-Antoine Hospital and Sorbonne University in Paris, France. He also leads a translational research team (INSERM team) at the Saint-Antoine Research Center, Paris, France. Prof. Mohty is the Chairman of the Acute Leukemia Working Party
Diagnosis and management of chronic GVHD Read More »
María Queralt Salas María Queralt Salas, MD, PhD. Hematopoietic Transplantation Unit, Hospital Clínic de Barcelona. Institute of Cancer and Blood Diseases (ICAMS), Hospital Clínic de Barcelona, Spain
Optimal GVHD prophylaxis Read More »
Ernst Holler Prof Ernst Holler was trained as a hematologist and worked as an attending in the Munich allogeneic transplant program under the supervision of Prof Hans Jochem Kolb from 1980 until 1998. He was head of the clinical and experimental allogeneic transplant program at the University of Regensburg from 1998 until his retirement in
Acute and Chronic GVHD pathophysiology – Oct 7, 2024 Read More »
Florent Malard Florent Malard, MD, PhD, Professor of Hematology at Sorbonne Université and Saint-Antoine Hospital, Paris, France. His research works focused on allogeneic hematopoietic cell transplantation, immunology, microbiota and multiple myeloma.
Diagnosis and management of acute GVHD Read More »
Arnon Nagler Arnon Nagler, MD, MSc, Director of the Division of Hematology, Chaim Sheba Medical Center, Israel. Director of Bone Marrow transplantation and Cord Blood Bank, Chaim Sheba Medical Center, Israel. Leader of the RIC subcommittee of the ALWP of the EBMT – since 2010. Serves on the Editorial Board of several BMT and Hematology
Optimal choice of the conditioning regimen Read More »
